BOSTON (CBS/AP) – The drug maker Moderna has shipped a potential coronavirus vaccine for humans to government researchers for testing.

Shares of the biotech company soared early Tuesday, a day after the company said it sent vials to the National Institute of Allergy and Infectious Diseases for early-stage testing in the United States.

READ MORE: Has The Delta Variant Disappeared? Dr. Mallika Marshall Answers Your COVID-19 Questions

Moderna Therapeutics lab in Norwood. (Image credit: CBS News)

More than 80,000 people have been infected globally from the viral outbreak that began late last year in China. A total of 35 cases have been reported in the United States, including one in Massachusetts.

Read: CDC On Coronavirus

READ MORE: I-Team: Senators Demand Independent Review Of Seabrook Nuclear Power Plant

More than 2,600 people have died from the virus in mainland China, including one U.S. citizen.

Read: Why Coronavirus Is Dangerous

Shares of Moderna Inc., based in Cambridge, Massachusetts, jumped nearly 16% in premarket trading.

The stock started trading in late 2018 and set an all-time high price of $29.79 last April, according to FactSet.

MORE NEWS: Tax Season Has Started, Here Are Tips For A Timely Refund From The IRS

(© Copyright 2020 CBS Broadcasting Inc. All Rights Reserved. The Associated Press contributed to this report.)